State of Wyoming’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $239K | Sell |
26,650
-2,732
| -9% | -$24.5K | 0.03% | 792 |
|
|
2025
Q1 | $220K | Sell |
29,382
-12,921
| -31% | -$96.9K | 0.03% | 746 |
|
|
2024
Q4 | $318K | Sell |
42,303
-10,214
| -19% | -$76.8K | 0.04% | 518 |
|
|
2024
Q3 | $399K | Buy |
52,517
+45,682
| +668% | +$347K | 0.06% | 281 |
|
|
2024
Q2 | $42.2K | Sell |
6,835
-4,083
| -37% | -$25.2K | 0.01% | 1377 |
|
|
2024
Q1 | $55.5K | Buy |
10,918
+7,079
| +184% | +$36K | 0.01% | 1262 |
|
|
2023
Q4 | $23K | Buy |
3,839
+481
| +14% | +$2.88K | ﹤0.01% | 1536 |
|
|
2023
Q3 | $23.8K | Buy |
3,358
+1,128
| +51% | +$7.99K | 0.01% | 1486 |
|
|
2023
Q2 | $15.7K | Buy |
2,230
+988
| +80% | +$6.96K | ﹤0.01% | 1442 |
|
|
2023
Q1 | $10.4K | Sell |
1,242
-1,789
| -59% | -$14.9K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $34.8K | Buy |
+3,031
| New | +$34.8K | 0.01% | 1171 |
|
|
2022
Q3 | – | Sell |
-1,082
| Closed | -$11K | – | 1551 |
|
|
2022
Q2 | $11K | Buy |
1,082
+261
| +32% | +$2.65K | 0.01% | 1621 |
|
|
2022
Q1 | $13K | Buy |
821
+138
| +20% | +$2.19K | 0.01% | 1560 |
|
|
2021
Q4 | $9K | Sell |
683
-37
| -5% | -$488 | ﹤0.01% | 1680 |
|
|
2021
Q3 | $10K | Sell |
720
-346
| -32% | -$4.81K | 0.01% | 1024 |
|
|
2021
Q2 | $17K | Buy |
1,066
+565
| +113% | +$9.01K | 0.01% | 949 |
|
|
2021
Q1 | $5K | Buy |
+501
| New | +$5K | 0.01% | 439 |
|